Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiphospholipid Syndrome (APS)”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)UnknownNCT05983952
What this trial is testing

Anti-CD38 Antibody Treating APS With Thrombocytopenia

Who this might be right for
Antiphospholipid SyndromeThrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableLooking for participantsNCT05646394
What this trial is testing

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Who this might be right for
Antiphospholipid SyndromeArterial Thrombosis
McMaster University 150
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Not applicableStudy completedNCT01787305
What this trial is testing

Pilot Study of Gut Commensals in Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
Yale University 16
Testing effectiveness (Phase 2)Ended earlyNCT02595346
What this trial is testing

Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
University Hospital, Rouen 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06504420
What this trial is testing

The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study

Who this might be right for
Primary Antiphospholipid Syndrome
Peking University People's Hospital 70
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Ended earlyNCT05078710
What this trial is testing

Telitacicept in Primary APS Patients

Who this might be right for
Anti Phospholipid Syndrome
Peking Union Medical College Hospital 20
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Not Yet RecruitingNCT07439029
What this trial is testing

YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Diffuse Systemic SclerosisIdiopathic Inflammatory Myopathies (IIMs)+3 more
Children's Hospital of Fudan University 12
Post-approval studies (Phase 4)UnknownNCT02303171
What this trial is testing

Use of Warfarin After the First Trimester in Pregnant Women With APS

Who this might be right for
Recurrent MiscarriageAntiphospholipid Syndrome
Mohamed Sayed Abdelhafez 100
Not applicableUnknownNCT01661439
What this trial is testing

Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome

Who this might be right for
Recurrent Pregnancy LossesPositive Anti Phospholipid Syndrome
Woman's Health University Hospital, Egypt 316
Not applicableLooking for participantsNCT04262492
What this trial is testing

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Who this might be right for
Antiphospholipid SyndromeThrombosisAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily 500
Not applicableUnknownNCT05644210
What this trial is testing

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Who this might be right for
Antiphospholipid Syndrome
Qilu Hospital of Shandong University 80
Testing effectiveness (Phase 2)Looking for participantsNCT03152058
What this trial is testing

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Who this might be right for
High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in Pregnancy+1 more
David Ware Branch 55
Not applicableLooking for participantsNCT00198068
What this trial is testing

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Syndrome
Hospital for Special Surgery, New York 700
Post-approval studies (Phase 4)Study completedNCT02326051
What this trial is testing

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Who this might be right for
Recurrent MiscarriageAntiphospholipid Syndrome
Mohamed Sayed Abdelhafez 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05995600
What this trial is testing

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Who this might be right for
Antiphospholipid SyndromeIschemic StrokeTransient Ischemic Attack+3 more
Seoul National University Hospital 200
Next Page